An Analysis of the Liver Transplant Waiting List at the G. G. Kuvatov Republican Clinical Hospital

Introduction. Liver transplantation is currently considered to be the only method of radical treatment for adults and children with incurable liver diseases. The most important aspects of liver transplantation are the correct selection of an appropriate recipient and compilation and maintenance of a liver transplant waiting list. This article aims to analyze the structure of the severe chronic liver disease patient population included in the liver transplant waiting list at the G. G. Kuvatov Republican Clinical Hospital (the City of Ufa).

Materials and methods. We analyzed the waiting list drawn and maintained over the 2007-2018 period based on the examination of 789 patients with liver cirrhosis of various etiologies.

Results and discussion. Out of all the patients with liver cirrhosis of different etiologies (Child-Pugh score classes A, B, and C) 149 (18.8 %) were included in the waiting list. The ages of patients included in the liver transplant waiting list ranged from 19 to 69. The mortality rate amounted to 38.9 % (58 people); of these patients 31 (53.4 %) had hepatic cirrhosis (HC) of autoimmune etiology, 18 (31.0 %) — HC of viral etiology, and 6 (10.3 %) — alveococcosis of the liver. The rate of the waiting list expansion for patients aged 20-29 compared to those aged 0-19 amounted to 1.32 %. Such a dynamics for the 30-39 age group compared to the 20-29 age group was 11.51 %. The number of people aged 40-49 compared to the preceding age group remained the same.

Conclusion. Our analysis of the waiting list sets the percentage of patients with autoimmune HC in the population of patients with this disease at 59 %. These patients are characterized by a rapid progression of liver failure and high mortality. The statistical analysis of liver transplant waiting lists facilitate the optimization of procedures used to select and manage such patients, as well as to prevent, in a timely manner, the development of complications thus improving the prognosis of survival.

1. Maynard E. Liver transplantation: patient selection, perioperative surgical issues, and expected outcomes. Surg Clin North Am. 2019;99(1):65-72. DOI: 10.1016/j.suc.2018.09.005

2. Wu C., Lu C., Xu C. Short-term and long-term outcomes of liver transplantation using moderately and severely steatotic donor livers: a systematic review. Medicine (Baltimore). 2018;97(35):e12026. DOI: 10.1097/MD.0000000000012026

3. Gautier S.V., Khomyakov S.M. Organ donation and transplantation in Russian Federation in 2017. 10th report of the National Registry. Russian journal of transplantology and artificial organs. 2018;20(2):6-28 (In Russ.). DOI: 10.15825/1995-1191-2018-2-6-28

4. Bessonova E.N., Klimusheva N.F., Glasyrina Yu.A. Singularity of group management of the patients on liver transplantation waiting list. Russian journal of transplantology and artificial organs. 2015;17(2):105-6 (In Russ.).

5. Mehta N., Dodge J.L., Hirose R., Roberts J.P., Yao F.Y. Increasing liver transplantation wait-list dropout for hepatocellular carcinoma with widening geographical disparities: implications for organ allocation. Liver Transpl. 2018;24(10):1346-56 DOI: 10.1002/lt.25317

6. Samuel D., Coilly A. Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation. BMC Med. 2018;16:113. DOI: 10.1186/s12916-018-1110-y

7. Chistenko G.N., Rummo O.O., Scherba A.E. The waiting list for liver transplantation: state, problems, prospects. Medical journal. 2016;(3):142-6 (In Russ.).

8. Moysyuk Y.G., Poptsov V.N., Sushkov A.I., Moysyuk L.Y., Malinovskaya Y.O., Belskikh L.V Early liver allograft dysfunction: risk factors, clinical course and outcomes. The Russian Journal of Transplantation. 2016;(2):16-28 (In Russ.).

9. Nartaylakov M.A., Kurbangulov I.R., Musin I.R., Nuriakhmetov R.R., Abdeev R.R., Zagitov A.R. Organizational and clinical aspects of multiorgan donation. Bulletin Bashkir State Medical University. 2015;(5):56-63 (In Russ.).

10. Nartaylakov M.A., Abdeev R.R., Kurbangulov I.R., Gritsaenko A.I., Zagitov A.R., Mukhamedjanov G.K. Difficulties in the development of liver transplantation. Vesntik KazNMU. 2015;(1):223-6 (In Russ.).

11. Moon D.-B., Lee S.-G., Kang W.-H., Song G.-W., Jung D.-H., Park G.-C., et al. Adult living donor liver transplantation for acute-on-chronic liver failure in high-model for end-stage liver disease score patients. Am J Transplant. 2017;17(7):1833-42. DOI: 10.1111/ajt.14198

12. Wedd J., Bambha K.M., Stotts M., Laskey H., Colmenero J., Gralla J., et al. Stage of cirrhosis predicts risk of liver related death in low MELD patients with cirrhosis awaiting liver transplant. Liver Transpl. 2014;20(10):1193-201. DOI: 10.1002/lt.23929

13. Lee H., Yoon S., Oh S.-Y., Shin J., Kim J., Jung Ch.-W., et al. Comparison of APACHE IV with APACHE II, SAPS 3, MELD, MELD-Na, and CTP scores in predicting mortality after liver transplantation. Sci Rep. 2017;7:10884. DOI: 10.1038/s41598-017-07797-2

14. Blechacz B. Cholangiocarcinoma: current knowledge and new developments. Gut Liver. 2017;11(1):13-26. DOI: 10.5009/gnl15568

15. Lai Q., Lerut J. Proposal for an algorithm for liver transplantation in Caroli’s disease and syndrome: putting an uncommon effort into a common task. Clin Transplant. 2016;30(1):3-9. DOI: 10.1111/ctr.12640

16. Huang A.C., Mehta N., Dodge J.L., Yao F.Y., Terrault N.A. Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout. Hepatology. 2018;68(2):449-61. DOI: 10.1002/hep.29855